We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
-11.61%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.12B
AUM Growth
-$212M
Cap. Flow
-$32.2M
Cap. Flow %
-2.87%
Top 10 Hldgs %
21.39%
Holding
1,938
New
397
Increased
563
Reduced
612
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 16.01%
2 Healthcare 15.85%
3 Financials 12.29%
4 Consumer Discretionary 8.51%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNC
1601
DELISTED
GNC Holdings, Inc.
GNC
$2K ﹤0.01%
951
-284
-23% -$955
WBC
1602
DELISTED
WABCO HOLDINGS INC.
WBC
$2K ﹤0.01%
+17
New +$1.88K
FTSV
1603
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$2K ﹤0.01%
+158
New +$2.41K
INAP
1604
DELISTED
Internap Corporation
INAP
$2K ﹤0.01%
419
-2,345
-85% -$17.4K
CRR
1605
DELISTED
Carbo Ceramics Inc.
CRR
$2K ﹤0.01%
+496
New +$2.48K
DFRG
1606
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$2K ﹤0.01%
228
-242
-51% -$1.71K
PES
1607
DELISTED
Pioneer Energy Services Corp.
PES
$2K ﹤0.01%
2,367
-5,118
-68% -$12.7K
AMBR
1608
DELISTED
Amber Road Inc
AMBR
$2K ﹤0.01%
+249
New +$2.2K
INSY
1609
DELISTED
Insys Therapeutics, Inc.
INSY
$2K ﹤0.01%
567
+230
+68% +$1.6K
QADA
1610
DELISTED
QAD Inc.
QADA
$2K ﹤0.01%
47
KEG
1611
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$2K ﹤0.01%
+1,019
New +$7.44K
IMDZ
1612
DELISTED
Immune Design Corp.
IMDZ
$2K ﹤0.01%
+1,818
New +$3.16K
ABEO icon
1613
Abeona Therapeutics
ABEO
$394M
$1K ﹤0.01%
+6
New +$1.31K
ALTO icon
1614
Alto Ingredients
ALTO
$356M
$1K ﹤0.01%
1,527
-3,531
-70% -$5.83K
ATEX icon
1615
Anterix
ATEX
$1.97B
$1K ﹤0.01%
+31
New +$1.21K
BBWI icon
1616
Bath & Body Works
BBWI
$4.12B
$1K ﹤0.01%
49
-979
-95% -$24.7K
BOOM icon
1617
DMC Global
BOOM
$150M
$1K ﹤0.01%
+50
New +$1.82K
BOOT icon
1618
Boot Barn
BOOT
$4.91B
$1K ﹤0.01%
+75
New +$1.72K
BBBY
1619
Bed Bath & Beyond
BBBY
$429M
$1K ﹤0.01%
+102
New +$1.53K
CRVS icon
1620
Corvus Pharmaceuticals
CRVS
$1.19B
$1K ﹤0.01%
296
-280
-49% -$1.91K
CTRN icon
1621
Citi Trends
CTRN
$609M
$1K ﹤0.01%
+58
New +$1.37K
ECOR icon
1622
electroCore
ECOR
$58.9M
$1K ﹤0.01%
+15
New +$1.96K
ESE icon
1623
ESCO Technologies
ESE
$8.46B
$1K ﹤0.01%
+8
New +$520
EVC icon
1624
Entravision Communication
EVC
$1.06B
$1K ﹤0.01%
390
-8,294
-96% -$32.5K
FRO icon
1625
Frontline
FRO
$8.73B
$1K ﹤0.01%
+186
New +$1.22K

Similar funds

Meeder Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Meeder Asset Management held 1,938 positions worth $1.12B, down 16% from $1.33B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Meeder Asset Management's Q4 2018 filing shows 397 new, 563 increased, 612 reduced and 213 closed positions. Its largest new stake was Procter & Gamble: 60,334 shares worth $5.55M. The largest sale was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $23.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Meeder Asset Management's largest Q4 2018 buy was Procter & Gamble: 60,334 shares worth $5.55M.
  • Meeder Asset Management added most to iShares Core US Aggregate Bond ETF in Q4 2018, an estimated $29.9M increase.
  • Meeder Asset Management's biggest Q4 2018 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $23.9M.
  • Meeder Asset Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $4.28M.
  • Meeder Asset Management's ten largest holdings make up 21% of its $1.12B portfolio in Q4 2018.
  • Meeder Asset Management opened 397 new positions and closed 213 in Q4 2018.
  • Meeder Asset Management's portfolio value fell 16% quarter-over-quarter to $1.12B.

Based on Meeder Asset Management's 13F filing for Q4 2018, filed 17 Jan 2019.